Literature DB >> 10554062

Isoeugenol is an important contact allergen: can it be safely replaced with isoeugenyl acetate?

I R White1, J D Johansen, E G Arnau, J P Lepoittevin, S Rastogi, M Bruze, K E Andersen, P J Frosch, A Goossens, T Menné.   

Abstract

The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97-54-1) is an important individual allergen. Until May 1998, the IFRA (International Fragrance Association) guidelines suggested that isoeugenol could safely be used at a level of 0.2% in consumer products. In May 1998, IFRA recommended that isoeugenol should not be used at a level that exceeds 0.02% in consumer products, but did not provide guidance on allergen substitution. An alternative to isoeugenol, based on aroma and absence of guidelines on use, is isoeugenyl acetate (CAS 93-29-8). 155 consecutive subjects were patch tested to isoeugenyl acetate (1.2%, 0.4%, 0.13% eth.) and isoeugenol 1% pet. 6 (3.9%) had an allergic reaction to 1.2% isoeugenyl acetate at D4. The reactions to the other 2 dilutions tended to be graded. 8 individuals had at least a palpable erythema by D4 to isoeugenol 1% pet. The majority of individuals allergic to isoeugenol were also intolerant of isoeugenyl acetate. Effective labelling of fragrance substances on consumer products will facilitate monitoring of exposure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554062     DOI: 10.1111/j.1600-0536.1999.tb06160.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  2 in total

1.  Radical-scavenging activity of the reaction products of isoeugenol with thiol, thiophenol, mercaptothiazoline or mercaptomethylimidazole using the induction period method.

Authors:  Yoshinori Kadoma; Wakako Kumada; Yuhta Asai; Yoshiaki Sugita; Ichiro Yokoe; Seiichiro Fujisawa
Journal:  Molecules       Date:  2007-08-13       Impact factor: 4.411

2.  Expression and function of the ectopic olfactory receptor OR10G7 in patients with atopic dermatitis.

Authors:  Elizabeth Huiwen Tham; Nathan Dyjack; Byung Eui Kim; Cydney Rios; Max A Seibold; Donald Y M Leung; Elena Goleva
Journal:  J Allergy Clin Immunol       Date:  2018-11-14       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.